Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Adaptimmune Therapeutics PLC (ADAP)  
$1.19 0.00 (0.00%) as of 4:30 Thu 5/2


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 154,660,000
Market Cap: 184.05(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.429 - $1.75
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Adaptimmune Therapeutics is a biopharmaceutical company focused on developing T-cell therapies for solid tumors. Co.'s proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables it to identify cancer targets, find and genetically engineer T-cell receptors against those targets, and produce therapeutic candidates (SPEAR T-cells) for administration to patients. Co. has clinical trials on its ADP-A2M4, ADP-A2M4CD8, each targeting the MAGE-A4 antigen, and ADP-A2AFP SPEAR T-cells targeting the alpha fetoprotein (AFP) cancer antigen in solid tumor types including non-small cell lung cancer, head and neck cancer, ovarian, urothelial, melanoma, and hepatocellular.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 39,000
Total Buy Value $0 $0 $0 $11,326
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 0 165,799 218,930 354,372
Total Sell Value $0 $124,385 $172,782 $411,912
Total People Sold 0 4 5 6
Total Sell Transactions 0 16 19 41
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 234
  Page 2 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Norry Elliot Chief Medical Officer   •       –      –    2023-01-17 4 S $1.86 $4,011 D/D (2,159) 3,491 33%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2023-01-17 4 S $1.86 $18,686 D/D (10,057) 13,351 33%     
   Norry Elliot Chief Medical Officer   •       –      –    2023-01-12 4 S $1.71 $12,708 D/D (7,449) 12,191 33%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2023-01-12 4 S $1.71 $8,484 D/D (4,973) 8,121 33%     
   Lunger John Chief Patient Supply Officer   •       –      –    2023-01-12 4 S $1.71 $8,484 D/D (4,973) 8,121 33%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2023-01-12 4 S $1.71 $32,010 D/D (18,763) 24,882 33%     
   Norry Elliot Chief Medical Officer   •       –      –    2023-01-11 4 S $1.75 $6,713 D/D (3,843) 6,270 28%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2023-01-11 4 S $1.75 $6,713 D/D (3,843) 6,270 28%     
   Lunger John Chief Patient Supply Officer   •       –      –    2023-01-11 4 S $1.75 $6,713 D/D (3,843) 6,270 28%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2023-01-11 4 S $1.75 $22,782 D/D (13,042) 17,298 28%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2023-01-04 4 S $1.69 $8,594 D/D (5,073) 6,631 22%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2023-01-04 4 S $1.69 $6,071 D/D (3,584) 5,781 22%     
   Lunger John Chief Patient Supply Officer   •       –      –    2023-01-04 4 S $1.69 $1,863 D/D (1,100) 1,725 22%     
   Norry Elliot Chief Medical Officer   •       –      –    2023-01-04 4 S $1.69 $1,484 D/D (876) 1,361 22%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2022-09-01 4 S $1.97 $4,993 D/D (2,536) 3,316 3%     
   Piccina Cintia Chief Commercial Officer   •       –      –    2022-08-01 4 S $1.77 $37,314 D/D (21,040) 34,824 14%     
   Lunger John Chief Patient Supply Officer   •       –      –    2022-08-01 4 S $1.77 $5,290 D/D (2,983) 4,829 14%     
   Lunger John Chief Patient Supply Officer   •       –      –    2022-07-05 4 S $1.68 $3,311 D/D (1,973) 3,104 -51%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2022-06-27 4 S $1.63 $4,176 D/D (2,562) 3,290 6%     
   Wood Gavin Chief Financial Officer   •       –      –    2022-05-20 4 B $0.29 $11,326 D/D 39,000 96,000 2.74 -34%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2022-01-18 4 S $3.19 $35,416 D/D (11,096) 12,312 52%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2022-01-18 4 S $3.19 $13,942 D/D (4,368) 7,336 52%     
   Lunger John Chief Patient Supply Officer   •       –      –    2022-01-18 4 S $3.19 $13,942 D/D (4,368) 7,336 52%     
   Norry Elliot Chief Medical Officer   •       –      –    2022-01-18 4 S $3.19 $6,770 D/D (2,121) 3,529 52%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2022-01-12 4 S $3.54 $7,967 D/D (2,248) 3,754 56%     
  234 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us